Quest Diagnostics Incorporated

DGX
$215.72 (- $0.30 - 0.14%)
Last updated: 2026-07-03 20:11 UTC
DGX Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorHealthcare
IndustryDiagnostics & Research
ISINUS74834L1008
CUSIP74834L100
Market Price215.72
Dividend Yield 2.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 3.0
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyQuarterly
P/E Ratio20.59
EPS8.53
Market Cap$19.6B
Book Value65.39
Price to Book2.686
Beta0.62
52w High197.55
52w Low148.7
Next Earnings DateN/A

Quest Diagnostics Incorporated trades under ticker DGX on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US74834L1008, CUSIP 74834L100.

About the Company
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Price History